Semaglutide to Reduce Calorie Intake Slows Aging in Female Mice, as Might be Expected
Key claim: Commentary argues semaglutide slows aging in female mice largely because GLP-1 agonism suppresses appetite and cuts calorie intake, reproducing the well-known life-extending effect of caloric restriction rather than revealing a distinct GLP-1 aging mechanism.
Abstract
Without careful study design, studies in which the use of GLP-1 receptor agonists such as semaglutide lowered calorie intake significantly via suppression of appetite might be expected to teach us little that we did not already know. Reducing calorie intake without compromising minimum necessary levels of essential nutrients slows aging and extends life, whether achieved via limiting food availability or by limiting appetite. Researchers know this, and they know a great deal about the fine details of the metabolic response to reduced nutrient availability. The effects of reduced calorie intake readily overpowers the effects of other mechanisms that may or may not be operating as a result of GLP-1 receptor agonism, particularly in short-lived species. One has to look more carefully to see any more […]
Why this matters
Commentary argues semaglutide slows aging in female mice largely because GLP-1 agonism suppresses appetite and cuts calorie intake, reproducing the well-known life-extending effect of caloric restriction rather than revealing a distinct GLP-1 aging mechanism.